Semaglutide for PCOS (polycystic ovary syndrome) is off-label, but small trials suggest it can help with weight, insulin resistance and, possibly, menstrual cycles and natural pregnancy rates. A 2026 meta-analysis of 11 randomized trials of GLP-1 drugs in PCOS found modest weight loss (BMI down about 1.4 points versus control) but judged the evidence on periods, fertility and hormones too weak to draw conclusions.[1]
For how the drug works and its approved uses, see our semaglutide profile.
Why semaglutide is used in PCOS
PCOS is a common hormonal condition that can cause irregular periods, excess androgens (male-type hormones such as testosterone) and polycystic ovaries. Many people with PCOS also have insulin resistance and excess weight, which can worsen symptoms.
Semaglutide is a GLP-1 receptor agonist that reduces appetite and improves blood sugar control. The idea is that weight loss and better insulin sensitivity may ease the hormonal imbalance behind PCOS. A 2026 evidence review described semaglutide’s PCOS data as “sparse” but promising for weight loss and natural conception, and found liraglutide, an older GLP-1 drug, has the most PCOS-specific evidence.[5]
Is semaglutide approved for PCOS?
No. Semaglutide is FDA-approved as:[6]
- Wegovy: chronic weight management, cardiovascular risk reduction and MASH liver disease.
- Ozempic and Rybelsus: type 2 diabetes.
A person with PCOS who meets Wegovy’s weight criteria (BMI of 30 or more, or 27 or more with a weight-related condition) can be prescribed it for weight management, which is an approved use. Prescribing it to treat PCOS symptoms themselves is off-label. Insurance coverage for weight-loss drugs varies, and plans may not accept PCOS alone as a reason.
What the evidence shows
| Outcome | What studies found | Strength of evidence |
|---|---|---|
| Weight and BMI | GLP-1 drugs reduced BMI by about 1.4 points vs control[1] | Low certainty, but consistent |
| Insulin resistance | Improved HOMA-IR (a measure of insulin resistance)[2] | Small trials |
| Menstrual regularity | Improved in one meta-analysis;[2] insufficient evidence in another[1] | Uncertain |
| Natural pregnancy | Higher rates (risk ratio 1.72)[2] | Small trials, mostly older GLP-1 drugs |
| IVF pregnancy | No significant difference[2] | Small trials |
| Testosterone | Slight reduction in total testosterone[2] | Small trials |
Most trials in these reviews used liraglutide or exenatide, not semaglutide, and many lasted only a few months.[1][2]
Semaglutide-specific trials
- Metformin plus semaglutide (2025): 100 women with PCOS and overweight or obesity received metformin alone or metformin plus semaglutide 1 mg weekly for 16 weeks. The combination group lost more weight (6.1 kg vs 2.3 kg), had larger drops in testosterone and inflammation, and more often regained regular cycles. Over the following 24 weeks on metformin alone, natural pregnancy rates were 35% versus 15%.[3] The trial was open-label, and 20% of participants did not finish.
- Taste and food reward (2025): in a placebo-controlled study of women with obesity and PCOS, semaglutide 1 mg improved taste recognition and changed brain responses to sweet tastes.[7]
- After stopping (2024): 25 women with PCOS who took semaglutide 1 mg and then stopped, while staying on metformin, regained about a third of the lost weight over two years. Most (21 of 25) still weighed less than at the start.[4]
Who might consider it
Semaglutide for PCOS is usually discussed with people who:
- Meet Wegovy’s weight criteria, so the drug can be prescribed for its approved weight-management use.[6]
- Have not reached their goals with diet, activity and metformin alone.[3]
- Are not pregnant, not breastfeeding and not planning pregnancy within the next few months.[6]
- Have no personal or family history of medullary thyroid cancer or MEN 2, which rule out semaglutide.[6]
It is less likely to be a fit for people with PCOS who are at a healthy weight, since the trials enrolled women with overweight or obesity and the benefits appear to come largely from weight loss.[1][3] Lean PCOS has not been studied with semaglutide. Your clinician will consider your symptoms, goals and other treatments.
Fertility and pregnancy cautions
Weight loss can restore ovulation in some people with PCOS. This has two sides.
- Unplanned pregnancy: ovulation can return before regular periods do. If you could become pregnant and are not trying to, discuss contraception with your clinician before starting.
- Stopping before pregnancy: because semaglutide may harm a developing baby, the Wegovy label says to stop at least 2 months before a planned pregnancy, to allow for its long half-life.[6]
- If you become pregnant: the label says to stop Wegovy when pregnancy is recognized.[6]
In practice, semaglutide in PCOS is usually a pre-conception tool: used to lose weight first, then stopped with a planned gap before trying to conceive. The 2025 trial followed this pattern, stopping semaglutide before measuring pregnancy rates.[3]
Semaglutide vs metformin for PCOS
Metformin is a long-standing treatment for insulin resistance in PCOS. Semaglutide appears more effective for weight loss, and in trials it is often added to metformin rather than replacing it.[3][4] For a broader comparison, see metformin vs semaglutide.
Dosing and side effects
PCOS trials of semaglutide used 1 mg weekly.[3][7] For weight management, Wegovy starts at 0.25 mg weekly and increases monthly to a usual maintenance dose of 2.4 mg; a clinician sets the dose and pace.[6] See our semaglutide dosage chart for each step.
Side effects are the same as in other users, mainly nausea, diarrhea, vomiting and constipation.[6] The labels also carry a boxed warning about thyroid tumors seen in rodents; see semaglutide and cancer risk. Some people notice changes in appetite and mood; our guide to Ozempic personality changes covers what the data show.
The bottom line
Semaglutide can help people with PCOS lose weight, and early studies suggest benefits for insulin resistance, cycles and natural conception. The evidence is limited, mostly short-term and often based on older GLP-1 drugs. Discuss contraception and pregnancy plans with your prescriber before starting. For expected weight results, see semaglutide weight loss results.
